The Board of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited proposed to declare a final dividend for Fiscal year 2025 on the basis of RMB 23.4 (inclusive of taxes) for every ten (10) shares in the capital of the Company. Subject to the Proposed Final Dividend being approved by shareholders at the 2026 AGM (as defined below), the Proposed Final Dividend will be paid in respect of all issued shares in the capital of the Company as at the record date to be determined by the Company for the purposes of determining shareholders' entitlements to the Proposed Final Dividend.